Abram L Wagner1, Amanda M Eccleston2, Rachel C Potter3, Robert G Swanson3, Matthew L Boulton4. 1. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan. Electronic address: awag@umich.edu. 2. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan. 3. Division of Immunizations, Michigan Department of Health and Human Services, Lansing, Michigan. 4. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan.
Abstract
INTRODUCTION: Delays in vaccination can stymie the development of herd immunity, and a large proportion of children in the U.S. are known not to receive vaccines on time. This study quantifies delays in vaccination, compares vaccination timeliness to the proportion of children vaccinated, and evaluates the impact of combination vaccine use and timely administration of hepatitis B vaccine birth dose on vaccine timeliness among Michigan children. METHODS: This retrospective cohort study used data from the Michigan Care Improvement Registry-the state immunization information system-for children born 2006-2010. Children aged 24 months as of December 31, 2012, were included. The proportion of children with timely administration of vaccine doses was calculated, and the mean days of vaccination delay with SD were reported. RESULTS: Among 620,592 Michigan children, 42.2% had received all vaccines, but only 13.2% were vaccinated on time by age 24 months. Children's vaccinations were delayed an average of 59.2 (SD=91.2) days by age 24 months for all recommended vaccine doses. Children who received a timely hepatitis B vaccine birth dose or who received a combination vaccine had less delay in vaccination. CONCLUSIONS: Michigan children have high vaccination coverage based on standard measures but few receive these vaccines on time. Promoting use of combination vaccines may improve parental compliance with timely vaccination of children.
INTRODUCTION: Delays in vaccination can stymie the development of herd immunity, and a large proportion of children in the U.S. are known not to receive vaccines on time. This study quantifies delays in vaccination, compares vaccination timeliness to the proportion of children vaccinated, and evaluates the impact of combination vaccine use and timely administration of hepatitis B vaccine birth dose on vaccine timeliness among Michigan children. METHODS: This retrospective cohort study used data from the Michigan Care Improvement Registry-the state immunization information system-for children born 2006-2010. Children aged 24 months as of December 31, 2012, were included. The proportion of children with timely administration of vaccine doses was calculated, and the mean days of vaccination delay with SD were reported. RESULTS: Among 620,592 Michigan children, 42.2% had received all vaccines, but only 13.2% were vaccinated on time by age 24 months. Children's vaccinations were delayed an average of 59.2 (SD=91.2) days by age 24 months for all recommended vaccine doses. Children who received a timely hepatitis B vaccine birth dose or who received a combination vaccine had less delay in vaccination. CONCLUSIONS: Michigan children have high vaccination coverage based on standard measures but few receive these vaccines on time. Promoting use of combination vaccines may improve parental compliance with timely vaccination of children.
Authors: Natalia V Oster; Emily C Williams; Joseph M Unger; Polly A Newcomb; Elizabeth N Jacobson; M Patricia deHart; Janet A Englund; Annika M Hofstetter Journal: Am J Prev Med Date: 2019-10 Impact factor: 5.043
Authors: See Ling Loy; Yin Bun Cheung; Jerry Kok Yen Chan; Shu E Soh; Keith M Godfrey; Kok Hian Tan; Lynette Pei-Chi Shek; Yap-Seng Chong; Ngee Lek; Fabian Yap; Oon Hoe Teoh; Chee Fu Yung; Koh Cheng Thoon Journal: Prev Sci Date: 2020-04
Authors: Sophia R Newcomer; Rain E Freeman; Bekki K Wehner; Stacey L Anderson; Matthew F Daley Journal: Am J Prev Med Date: 2021-05-08 Impact factor: 6.604